Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Signal Transduction and Targeted Therapy
|
January 21, 2025
Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms
Martina Rausch, Karlotta Bartels, Josef Leibold
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers
Josef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]
Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Nature Medicine
|
December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Nature Medicine
|
January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Theranostics
|
February 16, 2026
Modeling immunotherapies in live 3D human cancer tissue bioreactors
Yizheng Zhang, Ivan Foth, Ahmad Makky, et al.
Nature Cancer
|
January 4, 2024
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease
Josef Leibold, Kaloyan M Tsanov, Corina Amor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2022
Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer
Stella V Paffenholz, Camilla Salvagno, Yu-Jui Ho, et al.
Cancer Discovery
|
February 26, 2026
Integrated chronic in vivo and in vitro screens uncover NFIL3 as a driver of T cell dysfunction
Nayan Jain, Yuzhe Shi, Celina May, et al.
Cell
|
August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
Viraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Signal Transduction and Targeted Therapy
|
January 21, 2025
Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms
Martina Rausch, Karlotta Bartels, Josef Leibold
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers
Josef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]
Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Nature Medicine
|
December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Nature Medicine
|
January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Theranostics
|
February 16, 2026
Modeling immunotherapies in live 3D human cancer tissue bioreactors
Yizheng Zhang, Ivan Foth, Ahmad Makky, et al.
Nature Cancer
|
January 4, 2024
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease
Josef Leibold, Kaloyan M Tsanov, Corina Amor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2022
Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer
Stella V Paffenholz, Camilla Salvagno, Yu-Jui Ho, et al.
Cancer Discovery
|
February 26, 2026
Integrated chronic in vivo and in vitro screens uncover NFIL3 as a driver of T cell dysfunction
Nayan Jain, Yuzhe Shi, Celina May, et al.
Cell
|
August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
Viraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Page
of 3